Hangzhou Biotest Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	169.52	106.61	773.63	833.59
Depreciation & Amortization	22.62	29.17	23.25	10.53
Other Amortization	0.11	0.1	0.08	0.1
Loss (Gain) From Sale of Assets	0.33	-0	-	0
Asset Writedown & Restructuring Costs	-	6.35	18.78	-
Loss (Gain) From Sale of Investments	-7.05	-3.38	-14.85	-1.07
Provision & Write-off of Bad Debts	3.52	3.67	-5.59	3.21
Other Operating Activities	11.05	36.27	-48.37	29.38
Change in Accounts Receivable	-39.78	-13.57	107.84	-51.4
Change in Inventory	3.13	-14.14	-48.93	-60.84
Change in Accounts Payable	-43.09	-20.43	-98.94	145.05
Change in Other Net Operating Assets	6.53	2.46	5.31	1.05
Operating Cash Flow	128.83	131.38	703.21	908.12
Operating Cash Flow Growth	-1.94%	-81.32%	-22.56%	103.58%
Capital Expenditures	-245.05	-56.42	-178.92	-200.2
Sale of Property, Plant & Equipment	0.08	0.18	-	-
Investment in Securities	-601.82	126.76	260.84	-400
Other Investing Activities	8.54	3.84	14.79	0.23
Investing Cash Flow	-838.25	74.36	96.71	-599.97
Short-Term Debt Issued	-	0.24	-	5.56
Total Debt Issued	-	0.24	-	5.56
Short-Term Debt Repaid	-0.15	-	-5.29	-11
Long-Term Debt Repaid	-2.45	-4.17	-2.8	-2.46
Total Debt Repaid	-2.6	-4.17	-8.08	-13.46
Net Debt Issued (Repaid)	-2.6	-3.93	-8.08	-7.9
Issuance of Common Stock	24.87	4.17	-	856.14
Repurchase of Common Stock	-43.18	-14.76	-	-
Common Dividends Paid	-83.65	-234.67	-320.01	-20.91
Other Financing Activities	-	-	-4.56	-14.09
Financing Cash Flow	-104.55	-249.19	-332.65	813.24
Foreign Exchange Rate Adjustments	10.5	10.89	104.91	-14.82
Net Cash Flow	-803.48	-32.55	572.18	1,107
Free Cash Flow	-116.23	74.96	524.29	707.92
Free Cash Flow Growth	-	-85.70%	-25.94%	82.27%
Free Cash Flow Margin	-20.78%	16.95%	27.58%	38.94%
Free Cash Flow Per Share	-0.79	0.50	3.51	5.84
Cash Income Tax Paid	-0.27	3.48	143.63	67.92
Levered Free Cash Flow	-173.95	-18	279.64	443.47
Unlevered Free Cash Flow	-173.93	-17.91	279.77	443.89
Change in Working Capital	-71.28	-47.41	-43.71	32.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.